Rapamune

Generic name: Sirolimus

Usage of Rapamune

Rapamune weakens your body's immune system, to help keep it from "rejecting" a transplanted organ such as a kidney. Organ rejection happens when the immune system treats the new organ as an invader and attacks it.

Rapamune is a prescription medicine used to prevent rejection (anti-rejection medicine) in people 13 years of age and older who have received a kidney transplant. Rejection is when your body's immune system recognizes the new organ as a "foreign" threat and attacks it. Rapamune is used with other medicines called cyclosporine (Gengraf, Neoral, Sandimmune), and corticosteroids.

Rapamune is also given without other medicines to treat a rare lung disorder called lymphangioleiomyomatosis (LAM). LAM affects predominantly women of childbearing age. This disorder happens mostly in women and causes lung tumors that are not cancerous but can affect breathing.

Rapamune side effects

Rapamune may cause a serious brain infection that can lead to disability or death. Call your doctor right away if you have any change in your mental state, decreased vision, weakness on one side of your body, or problems with speech or walking. These symptoms may start gradually and get worse quickly.

Get emergency medical help if you have signs of an allergic Reaction to Rapamune: hives, rash, or peeling skin; wheezing, difficulty breathing, chest pain or tightness; feeling like you might pass out; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

redness, oozing, or slow healing of a skin wound;

a new skin lesion, or a mole that has changed in size or color;

unusual bleeding or bruising;

sudden chest pain or discomfort, cough, feeling short of breath;

tenderness around the transplanted kidney;

signs of infection - fever, chills, painful mouth sores, skin sores, cold or flu symptoms, pain or burning when you urinate; or

low red blood cells (anemia) - pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet.

Common Rapamune side effects may include:

fever, cold symptoms such as stuffy nose, sneezing, sore throat;

mouth sores;

nausea, stomach pain, diarrhea;

headache, muscle aches;

chest pain;

dizziness; or

acne.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Rapamune

You should not use Rapamune if you are allergic to sirolimus, or if you have ever had a lung transplant or liver transplant.

Talk with your doctor about the risks and benefits of using this medicine. Rapamune can affect your immune system, and may cause overproduction of certain white blood cells. This can lead to cancer, severe brain infection causing disability or death, or a viral infection causing kidney transplant failure.

To make sure Rapamune is safe for you, tell your doctor if you have ever had:

high cholesterol or triglycerides;

cytomegalovirus (CMV);

liver disease; or

a family history of skin cancer (melanoma).

Do not use Rapamune if you are pregnant. Use effective birth control to prevent pregnancy while you are taking this medicine, and for at least 12 weeks after your last dose.

You should not breast-feed while using this medicine.

Rapamune should not be given to a child younger than 13 years old.

How to use Rapamune

Usual Adult Dose of Rapamune for Organ Transplant -- Rejection Prophylaxis:

FOR PATIENTS AT LOW TO MODERATE IMMUNOLOGIC RISK: Dosing by body weight: -Less than 40 kg: Loading dose: 3 mg/m2 on day 1 Maintenance: 1 mg/m2 once daily -Greater than or equal to 40 kg: Loading dose: 6 mg orally on day 1 Maintenance: 2 mg orally once daily IN PATIENTS AT HIGH IMMUNOLOGIC RISK (defined as Black transplant recipients and/or repeat renal transplant recipients who lost a previous allograft for immunologic reason and/or patients with high-panel reactive antibodies [PRA; peak PRA level greater than 80%]): -For patients receiving sirolimus with cyclosporine: Loading Dose: Up to 15 mg on day one post-transplantation Maintenance Dose: Beginning on day 2, an initial maintenance dose of 5 mg/day should be given. A trough level should be obtained between days 5 and 7, and the daily dose of sirolimus should be adjusted thereafter. -Antibody induction therapy may be used. Comments: -It is recommended that this sirolimus be used in a regimen with cyclosporine and corticosteroids. -Sirolimus should be taken consistently with or without food. -Once the sirolimus maintenance dose is adjusted, patients should continue on the new maintenance dose for at least 7 to 14 days before further doSage adjustment with concentration monitoring. MAINTENANCE THERAPY AFTER WITHDRAWAL OF CYCLOSPORINE: -Cyclosporine withdrawal is not recommended in high-immunological risk patients. Following 2 to 4 months of combined therapy, withdrawal of cyclosporine may be considered in low-to-moderate risk patients. Cyclosporine should be discontinued over 4 to 8 weeks, and a necessary increase in the dosage of sirolimus (up to 4-fold) should be anticipated due to removal of metabolic inhibition by cyclosporine and to maintain adequate immunosuppressive effects. -Dose-adjusted trough target concentrations are typically 16 to 24 ng/mL for the first year post-transplant and 12 to 20 ng/mL thereafter (measured by chromatographic methodology).

Usual Adult Dose of Rapamune for Pulmonary Lymphangioleiomyomatosis:

-Initial dose: 2 mg/day -Sirolimus whole blood trough concentrations should be measured in 10 to 20 days, with dosage adjustment to maintain concentrations between 5 and 15 ng/mL. Comment: -This drug should be taken consistently with or without food.

Usual Pediatric Dose of Rapamune for Organ Transplant -- Rejection Prophylaxis:

FOR PATIENTS AT LOW TO MODERATE IMMUNOLOGIC RISK: Greater than or equal to 13 years of age: Dosing by body weight: -Less than 40 kg: Loading dose: 3 mg/m2 on day 1 Maintenance: 1 mg/m2 once daily -Greater than or equal to 40 kg: Loading dose: 6 mg orally on day 1 Maintenance: 2 mg orally once daily

Warnings

You should not use Rapamune if you have ever had a lung transplant or liver transplant.

Rapamune may cause your body to overproduce white blood cells. This can lead to cancer, severe brain infection causing disability or death, or a viral infection causing kidney transplant failure.

Call your doctor right away if you have: fever, flu symptoms, burning when you urinate, a new skin lesion, any change in your mental state, decreased vision, weakness on one side of your body, problems with speech or walking, or pain around your transplant.

What other drugs will affect Rapamune

Tell your doctor about all your current medicines. Many drugs can interact with Rapamune, especially:

Bromocriptine (Cycloset, Parlodel);

cyclosporine;

danazol;

St. John's wort;

tacrolimus;

cholesterol-lowering medication;

an antibiotic or antifungal medicine;

antiviral medicine to treat HIV or hepatitis C;

heart or blood pressure medication;

medicine to reduce stomach acid or treat an ulcer; or

seizure medicine.

This list is not complete and many Other drugs may interact with sirolimus. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.